Ebola Reston virus infection of pigs: clinical significance and transmission potential.
about
Membrane binding and bending in Ebola VP40 assembly and egressThe Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivoCurrent ebola vaccinesEbola and Marburg hemorrhagic fevers: neglected tropical diseases?Ebola virus antibodies in fruit bats, bangladeshTransmission of Ebola virus from pigs to non-human primatesMolecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequencesAerosol Transmission of FilovirusesEbolavirus Evolution: Past and PresentFiloviruses: One of These Things is (not) Like the OtherTransmission of Ebola viruses: what we know and what we do not knowNeglected filovirusesFiloviruses in bats: current knowledge and future directionsWhat is Ebola?Ebola: facing a new transboundary animal disease?A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola VirusRisks Posed by Reston, the Forgotten Ebolavirus.Characterization of the envelope glycoprotein of a novel filovirus, lloviu virusA seroepidemiologic study of Reston ebolavirus in swine in the PhilippinesRetinal Pigment Epithelial Cells are a Potential Reservoir for Ebola Virus in the Human Eye.Serological evidence of ebolavirus infection in bats, ChinaImmunopathogenesis of severe acute respiratory disease in Zaire ebolavirus-infected pigsElucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicityParticle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.Global trends in infectious diseases at the wildlife-livestock interface.Changes associated with Ebola virus adaptation to novel species.Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses.Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency.Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.Characterization of host immune responses in Ebola virus infections.A primer on Ebola for clinicians.Ecology of Filoviruses.Expression of the VP40 antigen from the Zaire ebolavirus in tobacco plants.Detection of Zaire ebolavirus in swine: Assay development and optimization.Vaccines against 'the other' Ebolavirus species.Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus.Ebola virus disease: history, epidemiology and outbreaks.Development of forensic assay signatures for ebolaviruses.Reston virus in domestic pigs in China.Ecological Niche Modeling for Filoviruses: A Risk Map for Ebola and Marburg Virus Disease Outbreaks in Uganda.
P2860
Q21131091-D6D8657A-8EC6-45C9-8D42-C6E15C834A48Q21131393-438FD0E9-3D9B-4F51-85A7-AF5D50E0EADDQ21534720-202DC92A-6212-431D-B591-2373A80E27C2Q21558510-B00AC8FF-E174-4220-B640-E242C146D77FQ22305631-247B429C-E3BB-41AF-B744-30F33F7658EFQ24612028-A774AA3C-C34D-4C3F-9DA1-2D74513E2E1FQ24621020-1419FE19-6A71-444D-A262-91E14FB04E6AQ26745989-0C3D27D9-B470-4476-A553-E0C80A2B89DBQ26777336-F1D00357-5D20-4A99-88C0-06CB5AF5AC94Q26783063-3D26C75A-CDF6-4ED5-8E40-2AC8F1611CF7Q28083565-38E5F595-1711-4E3A-9B2D-EB0A0DB2EA62Q28383265-0139BABB-BE0B-4E25-B9F6-453EE8201CB0Q28657754-85DE734C-FB8B-4599-BE02-1A29B2E02612Q30205723-5AC207F2-D7C2-4B77-BAC1-5D71C8353DEDQ30222969-177CA985-6E37-4F12-ADCD-08564BFB2F5DQ30235073-95D9193D-CA0C-488C-9625-EBF225E77897Q30239113-A41905F5-D6B2-47EB-BFA8-81727177E12FQ30391355-5A037FC1-44FD-498C-99D7-0FBBA427ACC6Q31065625-1A741B46-A4CE-424C-8982-49121552E07AQ33909208-728525F8-5185-4D70-A432-6B43CF444D14Q34643840-586AD562-5BCA-4257-9589-228A884F8AB0Q34692508-8BAC129C-8A1C-4C71-80CF-00253DAF7F4BQ34898131-52655490-90CF-4736-AD23-AAAD170A0A2DQ35745371-4540AE0F-29C0-4C29-ACBD-C442A258D641Q35946072-B1D80C9F-7866-48BA-9FAE-3FE70C749E66Q36281532-E29D7720-D1FE-4F9E-8EB8-3F8E13C86E45Q36724747-88710802-8578-41F0-9A86-FF84700DEA32Q36736898-DD97BDB6-03FA-4FD1-BBAD-86F4E5EA17A1Q37623149-742BFE2F-52CE-4246-B608-480F6589643DQ38205274-72BDBA52-911A-4998-8EA0-F2B1CFF4F6A1Q38261065-8F96E882-8681-4E72-8572-5B043B95F443Q38677951-4B5476BA-B873-42BC-86D6-5E5F437B366EQ38733265-AF86435A-CDA1-43F1-B57E-E2329DAEDE77Q40063813-58C0C550-AF05-45BB-9B0B-8AD716C2DEF7Q40112699-DB078C7F-EB85-4878-9783-F0EE6227022FQ40158371-194EB1B9-DB8E-4236-BEAD-4E5D73DB81BFQ40159475-72A10842-1CB8-46DA-83E7-7070B8FC52E4Q40169629-F513EDF0-6D67-43A1-AAAF-3CFD8FFDAA5DQ40273698-74FCFD68-D0DB-4FAC-BB56-BA41717682CDQ42364377-46A7FC43-332B-4291-8D1D-A4D98770874A
P2860
Ebola Reston virus infection of pigs: clinical significance and transmission potential.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Ebola Reston virus infection of pigs: clinical significance and transmission potential.
@en
type
label
Ebola Reston virus infection of pigs: clinical significance and transmission potential.
@en
prefLabel
Ebola Reston virus infection of pigs: clinical significance and transmission potential.
@en
P2093
P50
P356
P1476
Ebola Reston virus infection of pigs: clinical significance and transmission potential.
@en
P2093
Adam Foord
Deborah Middleton
Glenn A Marsh
Jean Payne
Jennifer A Barr
Jessica Haining
John Bingham
Manabu Yamada
Rachel Robinson
P304
P356
10.1093/INFDIS/JIR300
P407
P478
204 Suppl 3
P577
2011-11-01T00:00:00Z